The 3D correlation analysis indicated that high-risk neuroblastomas co-expressed PD-L1, PD-1, and CD163 (an M2 TAM marker) (Fig. 4A, D), suggesting the presence of M2-like TAMs with the PD-L1+PD-1+ phenotype. The gene discussed is CD274; the disease is neuroblastoma.